12 results · 31ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

INSTRUMENT TRAY LINER

FDA 510(k)
FDA Class 1 ·General, Plastic Surgery

PEEK Corpectomy

FDA UDI
Nuvasive, Inc.·00887517623072·PEEK Corp Core, Ø12x17mm

DyeVert Plus Contrast Reduction System, DyeVert NG Contrast Reduction System

FDA 510(k)
FDA Class 2 ·Cardiovascular

BLADDERSCAN BVI 9400 ULTRASOUND

FDA 510(k)
FDA Class 2 ·Radiology

PARIETEX UGYTEX PP ANTERIOR KIT X1

FDA Adverse Event
Injury ·SOFRADIM PRODUCTION·Product code FTL·February 6, 2013

PRECISION XTRA

FDA Adverse Event
Malfunction ·Product code NBW·January 26, 2011

TANDEM T:SLIM INSULIN DELIVERY SYSTEM

FDA Adverse Event
Injury ·TANDEM DIABETES CARE INC.·Product code LZG·July 8, 2014

COOK CELECT PLATINUM NAVALIGN FEMORAL VENA CAVA FILTER SET

FDA Adverse Event
Injury ·WILLIAM COOK EUROPE·Product code DTK·December 14, 2020

ACCESS SARS-COV-2 IGM

FDA Adverse Event
Malfunction ·CLARE DISCRETE MFG IO·Product code QKO·October 22, 2020

ACCESS SARS-COV-2 IGM

FDA Adverse Event
Malfunction ·CLARE DISCRETE MFG IO·Product code QKO·October 26, 2020

KLS Martin Cranial Implants - MR Conditional; K944565: KLS-Martin Micro Osteosynthesis System (1.5MM); K971297: KLS Martin Centre-Drive Drill-Free Screw; K060177: KLS Martin Rigid Fixation - Sterile; K062570: Individual Patient Solutions - Ti (IPS-Ti); K072707: Individual Patient Solutions - PEEK (IPS-PEEK) ; K151382: Individual Patient Solutions - (IPS-PEEK) - STERILE

FDA 510(k)
FDA Class 2 ·Neurology

Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017